University of Washington Medical Center PO-U-0000297228

NEURON-SPECIFIC ENOLASE CLONE BBS/NC/VI-H14 READY TO USE; ANTI-HUMAN CALDESMON CLONE H-CD, READY TO USE

The University of Washington Medical Center, a public hospital in Washington state, issued a purchase order to Agilent Technologies Inc for neuron-specific enolase clone BBS/NC/VI-H14 and anti-human caldesmon clone H-CD. The order includes 1 unit of the enolase clone and 2 units of the caldesmon clone, with a total obligated amount of $1,167. The procurement was made on February 28, 2025, and the products are intended for laboratory or medical research use. The award is a single-transaction contract, with no indication of a multi-year or blanket arrangement. The purchase involves specific biological reagents from Agilent Technologies, a recognized vendor in the biotech research sector.

Description

NEURON-SPECIFIC ENOLASE CLONE BBS/NC/VI-H14 READY TO USE; ANTI-HUMAN CALDESMON CLONE H-CD, READY TO USE